Patents by Inventor Aditi Bapat

Aditi Bapat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20160038498
    Abstract: The present invention is directed to methods for treating cancer in a subject, such as a cancer of the endocrine system. In some aspects, the method includes administering to the subject one or more of a polo-like kinase 1 inhibitor, a mouse double minute 2 inhibitor, and/or a mitotic catastrophe inducing compound. In other aspects, the method includes measuring an expression level of one or more markers, including caspase 8 and caspase 9, to assess the functionality of the caspase cascade in the subject.
    Type: Application
    Filed: October 23, 2015
    Publication date: February 11, 2016
    Applicant: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Kimberly J. Bussey, Michael J. Demeure, Aditi Bapat
  • Methods for the treatment of cancer
    Patent number: 9198910
    Abstract: The present invention is directed to methods for treating cancer in a subject, such as a cancer of the endocrine system. In some aspects, the method includes administering to the subject one or more of a polo-like kinase 1 inhibitor, a mouse double minute 2 inhibitor, and/or a mitotic catastrophe inducing compound. In other aspects, the method includes measuring an expression level of one or more markers, including caspase 8 and caspase 9, to assess the functionality of the caspase cascade in the subject.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: December 1, 2015
    Assignee: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Kimberly J. Bussey, Michael J. Demeure, Aditi Bapat
  • METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20140303120
    Abstract: The present invention is directed to methods for treating cancer in a subject, such as a cancer of the endocrine system. In some aspects, the method includes administering to the subject one or more of a polo-like kinase 1 inhibitor, a mouse double minute 2 inhibitor, and/or a mitotic catastrophe inducing compound. In other aspects, the method includes measuring an expression level of one or more markers, including caspase 8 and caspase 9, to assess the functionality of the caspase cascade in the subject.
    Type: Application
    Filed: April 4, 2014
    Publication date: October 9, 2014
    Applicant: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Kimberly J. Bussey, Michael J. Demeure, Aditi Bapat